What upcoming studies are focusing on cannabis and ankylosing spondylitis? 

The landscape of cannabis research is slowly evolving, with new trials aiming to clarify cannabis’s role in managing inflammatory conditions like ankylosing spondylitis. While early findings are promising, most large-scale studies remain in early phases or are limited to observational data. Still, several collaborative trials between universities, biotech firms, and patient organisations are underway. 

These trials are increasingly open to patient participation, offering individuals a chance to contribute to a growing body of knowledge. From investigating different cannabinoid ratios to testing strain-specific responses, these efforts are setting the groundwork for evidence-based guidelines. Some international studies are also comparing cannabis’s effects across different demographics and treatment environments. 

What We Know About the Research Pipeline 

Here are some promising directions currently shaping cannabis research: 

Symptom-specific studies 

Many trials are targeting sleep disruption, pain, and fatigue, core issues for AS patients. 

Comparative and observational trials 

Collaborative trials often compare cannabis with conventional treatments like NSAIDs or biologics. 

Emphasis on patient data 

Research increasingly values patient participation, with digital diaries and symptom tracking tools playing a major role. 

Global collaboration 

International studies are helping broaden insight into regional prescribing practices, strain availability, and outcomes. 

Visit providers like LeafEase  to learn how you can take part in future research or access care guided by the latest in cannabis research. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis and medical cannabis.